Patterns of anti-tuberculosis drug resistance among HIV-infected patients in Maputo, Mozambique, 2002-2003

International Journal of Tuberculosis and Lung Disease

Volumn 9, Issue 5, 2005, Pages 494-500

  Nunes, Elizabete A ^a,b   De Capitani, E M ^c   Coelho, E ^b   Joaquim, O A ^a   Figueiredo, I R O ^b   Cossa, A M ^b   Panunto, A C ^c   Carvalho Ramos, M ^c  

^a EDUARDO MONDLANE UNIVERSITY   (Mozambique)

^b MAPUTO CENTRAL HOSPITAL   (Mozambique)

^c UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Drug resistance; HIV; Multidrug resistance; Resistance pattern; Tuberculosis

Indexed keywords

BCG VACCINE; ETHAMBUTOL; HEMOGLOBIN; ISONIAZID; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; DRUG SENSITIVITY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; LABORATORY TEST; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MOZAMBIQUE; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; RADIODIAGNOSIS; SUPERINFECTION; TUBERCULOSIS;

ADULT; ANTIGENS, CD4; FEMALE; HIV INFECTIONS; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MOZAMBIQUE; RISK FACTORS; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 18444378769     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. World Health Organization/IUATLD - Global Project on Anti-tuberculosis Drug Resistance Surveillance. WHO/CDC/TB/2000. Geneva, Switzerland: Communicable Diseases, WHO, 2000.
2. World Health Organization. WHO World TB Day, 2003. Stop TB CDC/MOZ/2003. Geneva, Switzerland: WHO, 2003.
3. Nachega J B, Chaisson R E. Tuberculosis drug resistance: a global threat. CIm Infect Dis 2003; 36 (Suppl): 24-30.
4. World Health Organization. Report 2003 on Global Tuberculosis Control. Document Communicable Diseases. Geneva, Switzerland: WHO, 2003.
5. Mozambique Programa Nacional de Controle das DTS/HIV/SIDA. Relatório do Encontro para Divulgação dos Dados das taxas de prevalência do HIV/SIDA em Moçambique. Maputo, Mozambique: Ministry of Health, 2001.
6. Elliott M A, Namaambo K, Allen B W, et al. Negative sputum smear results in HIV-positive patients with pulmonary tuberculosis in Lusaka, Zambia. Tuberc Lung Dis 1993; 74: 191-194.
7. Bustreo F, Mendez A P, Raviglione M, Murray J, Trébucq A, Rieder H. Guidelines for surveillance of drug resistance in tuberculosis, 1996: WHO/TB/96.216. Geneva, Switzerland: WHO, 1997.
8. Stakteas S S, Vergara A V, Rayffield M R, Tanuri M R, Sam Gudo J S G, Barreto A B. Avaliacão laboratorial da Performance de diferentes testes rapidos e simples para deteccão de anticorpos contra HIV1/HIV2. Relatorio Final do Programa Nacional de Controle das DTS do Ministerio da Saude, Moçambique. Maputo, Mozambique: Ministry of Health, 2001.
9. Mac-Arthur A, Gloyd S, Perdigão P, Noya A, Sacarlal J, Kreiss J. Characteristics of drug resistance and HIV among tuberculosis patients in Mozambique. Int J Tuberc Lung Dis 2001; 5: 894-902.
10. Githui W, Nunn E, Juma E, et al. Cohort study of HIV-positive and HIV-negative tuberculosis, Nairobi, Kenya: comparison of bacteriological results. Tubercle Lung Dis 1992; 73: 203-209.
11. Bruchfeld J, Aderaye G, Palme I B, et al. Molecular epidemiology and drug resistance of Mycobacterium tuberculosis isolates from Ethiopian pulmonary tuberculosis patients with and without human immunodeficiency virus infection. J Clin Microbiol 2002; 40: 1636-1643.
12. Bretzel G, Aziz M, Wendl-Richer U, et al. Anti-tuberculosis drug resistance surveillance in Uganda 1996-1997. Int J Tuberc Lung Dis 1999; 3: 810-815.
13. Bercion R, Kuaban C. Initial Resistance to antituberculosis drugs in Younde, Cameroon in 1995. Int J Tuberc Lung Dis 1997; 1: 110-114
14. Koeck J L, Bernatas J J, Gerome P, et al. Epidemiology of resistance to antituberculosis drugs in Mycobacterium tuberculosis complex strains isolated from adenopathies in Djibouti. Prospective study carried out in 1999. Med Trop 2002; 62: 70-72.
15. Kuaban C, Bercion R, Jifon G, Cunin P, Blackett K N. Acquired anti-tuberculosis drug resistance in Yaounde, Cameroon. Int J Tuberc Lung Dis 2000; 4: 427-432.
16. Talbot E A, Kenyon T A, Mwasekaga M J, Moeti T L, Mallon V, Binkin N J. Control of anti-tuberculosis drug resistance in Botswana. Int J Tuberc Lung Dis 2003; 7: 72-74.
17. Pinto W P, Hadad D J, Palhares M C, et al. Drug resistance of M. tuberculosis isolated from patients with HIV infection seen at an AIDS Reference Center in São Paulo, Brazil. Rev Inst Med Trop (São Paulo) 1995; 38: 15-22.
18. Warndorff D K, Yates M, Ngwira B, et al. Trends in anti-tuberculosis drug resistance in Karonga District, Malawi, 1986-1998. Int J Tuberc Lung Dis 2000; 4: 752-757
19. Alrajhi A A, Abdulwahab S, Almodovar E, Al-Abdely H M. Risk factors for drug-resistant Mycobacterium tuberculosis in Saudi Arabia. Saudi Med J 2002; 23: 305-310.
20. Churchyard G J, Corbett E L, Kleinschmidt I, Mulder D, De Cock K M. Drug-resistant tuberculosis in South African gold miners: incidence and associated factors. Int J Tuberc Lung Dis 2000; 4: 433-440.
21. Law K F, Jagirdar J, Weiden M D, Bodkin M, Rom W N. Tuberculosis in HIV-positive patients: cellular response and immune activation in the lung. Am J Respir Crit Care Med 1996; 153: 1377-1384.
22. Spacek L A, Griswold M, Quinn T, Moore R D. Total lymphocyte count and hemoglobin combined in an algorithm to initiate the use of highly active antiretroviral therapy in resource-limited settings. AIDS 2003; 17: 1311-1317.
23. van Eijk A M, Ayisi J G, Ter Kuile F O, et al. HIV increases the risk of malaria in women of all gravidities in Kiumu, Kenya. AIDS 2003; 17: 595-602.
24. Ayisi J G, Van Eijk A M, Ter Kuile F O, et al. The effect of dual infection with HIV and malaria on pregnancy outcome in western Kenya. AIDS 2003; 17: 585-593.
25. Whitworth J, Morgan D, Qiqley M, et al. Effect of HIV-1 and increasing immunosuppression on malaria parasitaemia and clinical episodes in adults in rural Ugandan adults. A cohort study. Lancet 2000; 356: 1051-1056.